Diagnosis and prediction of recurrence and progression in superficial bladder cancers with DNA image cytometry and urinary cytology

BJU International

Volumn 85, Issue 4, 2000, Pages 434-436

  Desgrippes, A ^a   Izadifar, V ^a   Assailly, J ^b   Fontaine, E ^a   Beurton, D ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

DNA ploidy; Progression; Recurrence; Superficial bladder cancer; Urinary cytology

Indexed keywords

DNA;

ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; IMAGE CYTOMETRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PLOIDY; PREDICTION; PRIORITY JOURNAL; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

ANEUPLOIDY; DIPLOIDY; DISEASE PROGRESSION; DNA; HUMANS; IMAGE CYTOMETRY; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS;

EID: 0034089376     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.2000.00478.x-i1     Document Type: Article

References (15)

1. 1 Heney NM, Ahmed S, Flanagan MJ et al. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130: 1083-6
2. 2 Murphy WM. Urological Pathology. Philadelphia: WB Saunders Co., 1989: 65-71
3. 3 Raab SS, Lenel JC, Cohen MB. Low grade transitional cell carcinomas of the bladder. Cytologic diagnostic by key features as identified by logistic regression analysis. Cancer 1994; 74: 1621-6
4. 4 Murphy WM, Solowsky MS, Jukkola AF, Crabtree WN, Ford KS. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984; 53: 1555-65
5. 5 Mora LB, Nicosia SV, Pow-Sang JM et al. Ancillary techniques in the follow up of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients. J Urol 1996; 156: 49-55
6. 6 Slaton JW, Dinney CPN, Veltri RW et al. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder. J Urol 1997; 158: 806-11
7. 7 Katz RL, Sinkre PA, Zhang HH, Kidd L, Johnston D. Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy. Cancer 1997; 81: 354-64
8. 8 Schapers RF, Ploem-Zaaijer JJ, Pauwels RP et al. Image cytometric DNA analysis in transitional cell carcinoma of the bladder. Cancer 1993; 72: 182-9
9. 9 Nemoto R, Uchida K, Hattori K et al. S phase fraction of human bladder tumor measured in situ with bromodeoxy-uridine labeling. J Urol 1988; 139: 286-9
10. 10 Shaaban AA, Tribukait B, El Bedeiwy AFA, Ghoneim MA. Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry. J Urol 1990; 144: 884-7
11. 11 Gustafson H, Tribukait B, Espoti PL. The prognostic value of DNA analysis in primary carcinoma in situ of the urinary bladder. Scand J Urol Nepgrol 1982; 16: 141-6
12. 12 Blomjous ECM, Schipper NW, Baak JPA, Vos W, de Voogt HJ, Meijer CJLM. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Am J Clin Pathol 1989; 91: 243-8
13. 13 Habaik AS, Pow-Sang JM, Lockhart J, Nicosia SV. Role of DNA image cytometry in the flow up of patients with urinary tract transitional cell carcinoma. Anal Quant Cytol Histol 1993; 15: 115-23
14. 14 Murphy WM, Emerson LD, Chandler RW, Moinuddin SM, Solowsky MS. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J Urol 1986; 136: 815-9
15. 15 Jankevicius F, Shibayama T, Decken K et al. Dual-parameter immunoflow cytometry in diagnosis and follow-up of patients with bladder cancer. Eur Urol 1998; 34: 492-9